Oxford, United Kingdom

Noel Drury

This inventor holds 1 USPTO granted patent. Top assignee: Oxford Biomedica (UK) Limited. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noel Drury. Retrieved from https://idiyas.com/inventor/noel-drury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Noel Drury

Introduction

Noel Drury is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptide sequences and nucleotide sequences related to veterinary medicine.

Latest Patents

Noel Drury holds a patent for the Feline 5T4 antigen. This patent includes canine and feline 5T4 polypeptide sequences and nucleotide sequences encoding them. Additionally, it provides a vector system comprising a nucleic acid encoding 5T4 and a 5T4-specific agent.

Career Highlights

Noel Drury is associated with Oxford Biomedica (UK) Limited, where he has been instrumental in advancing research and development in the biotechnology sector. His work has implications for both veterinary and medical applications.

Collaborations

He has collaborated with notable colleagues such as Kevin Alan Myers and Miles William Carroll, contributing to various projects that enhance the understanding and treatment of diseases in animals.

Conclusion

Noel Drury's innovative work in biotechnology, particularly with the Feline 5T4 antigen, showcases his commitment to advancing veterinary medicine. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…